Basics Viridian Therapeutics, Inc. IPO Date: June 16, 2014 Sector: Healthcare Industry: Biotech Market Cap: $1.53B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 2.81% Avg Daily Range (30 D): $0.39 | 2.17% Avg Daily Range (90 D): $0.36 | 2.32% Institutional Daily Volume Avg Daily Volume: .53M Avg Daily Volume (30 D): .71M Avg Daily Volume (90 D): .63M Trade Size Avg Trade Size (Sh.): 67 Avg Trade Size (Sh.) (30 D): 59 Avg Trade Size (Sh.) (90 D): 55 Institutional Trades Total Inst.Trades: 1,676 Avg Inst. Trade: $1.93M Avg Inst. Trade (30 D): $1.66M Avg Inst. Trade (90 D): $1.54M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.62M Avg Closing Trade (30 D): $1.77M Avg Closing Trade (90 D): $1.75M Avg Closing Volume: 140.91K     News Aug 6, 2025 @ 4:28 PM Viridian (VRDN) Q2 Net Loss Widens 55% Source: Jesterai Oct 15, 2024 @ 3:45 PM Ophthalmic Disease Therapeutics Market Analysis by... Source: Researchandmarkets.Com Jul 4, 2024 @ 8:01 PM Thyroid Eye Disease Market to Accelerate Substanti... Source: Delveinsight Jun 6, 2024 @ 3:00 PM 7 Analysts Assess Viridian Therapeutics: What You ... Source: Benzinga Insights May 8, 2024 @ 12:25 PM Viridian Therapeutics, Inc. (VRDN) Reports Q1 Loss... Source: Zacks Equity Research Financials   TTM Q1 2025 Q3 2024 Basic EPS $-1.15 Diluted EPS $-1.15 Revenue $ .08M $ .07M $ .09M Gross Profit $ $ $ Net Income / Loss $ -100.74M $ -86.91M $ -76.69M Operating Income / Loss $ -106.77M $ -93.87M $ -83.48M Cost of Revenue $ $ $ Net Cash Flow $ 1.11M $ 16.62M $ 92.65M PE Ratio     Splits Nov 13, 2020:   1:15 Nov 07, 2016:   1:15